Tarasiuk O, Molteni L, Malacrida A, Nicolini G. The Role of NMNAT2/SARM1 in Neuropathy Development. Biology (Basel). 2024 Jan 22;13(1):61. doi: 10.3390/biology13010061. PMID: 38275737; PMCID: PMC10813049. https://pubmed.ncbi.nlm.nih.gov/38275737/
Paola Marmiroli
Associate ProfessorMD+39 02 6448 8124paola.marmiroli@unimib.it Paola Marmiroli Associated Professor in Human Anatomy EDUCATION Master Degree in Medicine and Surgery at the University of Milano “Statale”. Board in Neurology at the University of Milano “Statale”. POSITIONS From 1989 to
Considerations for establishing and maintaining international research collaboration: the example of chemotherapy-induced peripheral neurotoxicity (CIPN)-a white paper
Alberti P, Argyriou AA, Bruna J, Damaj MI, Faithfull S, Harding A, Hoke A, Knoerl R, Kolb N, Li T, Park SB, Staff NP, Tamburin S, Thomas S, Smith EL. Considerations for establishing and maintaining international research collaboration: the example
Valentina Carozzi
Assistant ProfessorPhD+39 02 6448 8294valentina.carozzi1@unimib.it ASSISTANT PROFESSOR IN ANATOMY AND HISTOLOGY SCOPUS Author ID: 23972336300, ORCID ID: 0000-0003-0963-7107 68 EDUCATION Valentina Alda Carozzi was born in Gallarate (Varese) in 1981. In 2005 she graduated in Medical Biotechnology (110/110 cum laude)
Restorative medicine
Mesenchymal stem cells are tested for their capacity to modulate the immune response in EAE and experimental neuropathies and as supportive agents in transplant experimental medicine
Innovative drug delivery
The use of different types of nanoparticles is tested for their toxicity and effectiveness in order to improve drug delivery in cellular systems and in vivo in oncology, neuroimmunology and CIPN models. The availability of advanced imaging techniques makes it
Multiple sclerosis
At the ENU innovative treatments for multiple sclerosis are tested in the EAE model, in parallel to pathogenetic studies in vivo, ex vivo and in vitro.Experimental studies on possible disease biomarkers are performed in collaboration with the Neuroimmunology Center at
Chemotherapy-induced peripheral neurotoxicity (CIPN)
Preclinical research Researchers working at the ENU have originally developed most of the available animal models of CIPN using different drugs (cisplatin, carboplatin, oxaliplatin, paclitaxel, docetaxel, bortezomib, epothilones, etc). Also effective in vitro screening models are available. Adult and embryonic
Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice
Li Y, Kazuki Y, Drabison T, Kobayashi K, Fujita KI, Xu Y, Jin Y, Ahmed E, Li J, Eisenmann ED, Baker SD, Cavaletti G, Sparreboom A, Hu S. Vincristine Disposition and Neurotoxicity Are Unchanged in Humanized CYP3A5 Mice. Drug Metab
Exploring the effect of novel TLR4 antagonists in chemotherapy-induced peripheral neurotoxicity
Project details ENU Team Leader: Olga Tarasiuk Other ENU members involved: Eleonora Pozzi Coordinator: Mohammed Shaik Funded by: University of Milan Bicocca Total Contribution: 40.000 € Project Duration in months: 12 Start Date: 02.01.2024 End Date: 31.12.2024 Abstract Chemotherapy-induced peripheral